Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis (Q30889903)

27 June 2017

1 reference

title

Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis (English)

1 reference

27 June 2017

0 references

cognitive dysfunction

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Maria Pia Amato

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Nicola De Stefano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Iris-Katharina Penner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paola Valsasina

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Massimo Filippi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

4

Christian Enzinger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

5

Jeroen J Geurts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

7

Alex Rovira

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

8

James F Sumowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

MAGNIMS Study Group

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

4 February 2015

1 reference

27 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

302-317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

Imaging cortical damage and dysfunction in multiple sclerosis

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Association between pathological and MRI findings in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

The contribution of MRI in assessing cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Measurement and clinical effect of grey matter pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

The pathologic substrate of magnetic resonance alterations in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Minimal neuropsychological assessment of MS patients: a consensus approach

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Reliable screening for neuropsychological impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Awareness of deficit in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Validity of performance scales for disability assessment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Multiple sclerosis and depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Fatigue and processing speed are related in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Executive function in multiple sclerosis. The role of frontal lobe pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Isolated U-fiber involvement in MS: preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

A multiparametric MRI study of frontal lobe dementia in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

The effect of medial frontal and posterior parietal demyelinating lesions on stroop interference.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Patterns of cognitive impairment in secondary progressive stable phase of multiple sclerosis: correlations with MRI findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Posterior fossa lesion volume and slowed information processing in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive impairment and structural brain damage in benign multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Correlates of cognitive dysfunction in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Relevance of brain lesion location to cognition in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

A longitudinal study of cognition in primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Clinical correlations of brain lesion distribution in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Brain pathways of verbal working memory: a lesion-function correlation study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Corpus callosum damage and cognitive dysfunction in benign MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Correlation of cognitive dysfunction and diffusion tensor MRI measures in patients with mild and moderate multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive deficits in multiple sclerosis correlate with changes in fronto-subcortical tracts.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Regional DTI differences in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

In vivo MR imaging of hippocampal lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cortical lesion load associates with progression of disability in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

3D MPRAGE improves classification of cortical lesions in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Thalamic atrophy and cognition in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Regional hippocampal atrophy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive functions in multiple sclerosis: impact of gray matter integrity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Gray matter damage predicts the accumulation of disability 13 years later in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis — A longitudinal voxel-based morphometry study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Structural and functional MRI correlates of Stroop control in benign MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Analysis of impairment related functional architecture in MS patients during performance of different attention tasks.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Functional MR imaging correlates of neuropsychological impairment in primary-progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

fMRI changes in relapsing-remitting multiple sclerosis patients complaining of fatigue after IFNbeta-1a injection.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

A default mode of brain function: a brief history of an evolving idea

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Default-mode network dysfunction and cognitive impairment in progressive MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Distributed changes in default-mode resting-state connectivity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Abnormalities of resting state functional connectivity are related to sustained attention deficits in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Assessing brain connectivity at rest is clinically relevant in early multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Reduced brain functional reserve and altered functional connectivity in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Reorganization in cognitive networks with progression of multiple sclerosis: insights from fMRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Altered functional adaptation to attention and working memory tasks with increasing complexity in relapsing-remitting multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures--an explorative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Resting state networks change in clinically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive reserve in ageing and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive reserve in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Brain reserve and cognitive reserve in multiple sclerosis: what you've got and how you use it

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Cognitive reserve and patient-reported outcomes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Memory enhancement in healthy older adults using a brain plasticity-based training program: a randomized, controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970250-9

7 January 2021

10.1016/S1474-4422(14)70250-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662900%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference